nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—Ketoprofen—CXCL8—atopic dermatitis	0.0113	1	CrCbGaD
Alvimopan—Urinary retention—Diphenhydramine—atopic dermatitis	0.0111	0.0577	CcSEcCtD
Alvimopan—Urinary retention—Dimenhydrinate—atopic dermatitis	0.0111	0.0577	CcSEcCtD
Alvimopan—Malnutrition—Pimecrolimus—atopic dermatitis	0.00679	0.0353	CcSEcCtD
Alvimopan—Back pain—Pimecrolimus—atopic dermatitis	0.00657	0.0342	CcSEcCtD
Alvimopan—Urinary retention—Tacrolimus—atopic dermatitis	0.00584	0.0304	CcSEcCtD
Alvimopan—Hypokalaemia—Tacrolimus—atopic dermatitis	0.00559	0.0291	CcSEcCtD
Alvimopan—Connective tissue disorder—Fluocinolone Acetonide—atopic dermatitis	0.00549	0.0286	CcSEcCtD
Alvimopan—Dyspepsia—Dimenhydrinate—atopic dermatitis	0.00505	0.0263	CcSEcCtD
Alvimopan—Dyspepsia—Diphenhydramine—atopic dermatitis	0.00505	0.0263	CcSEcCtD
Alvimopan—Constipation—Dimenhydrinate—atopic dermatitis	0.0049	0.0255	CcSEcCtD
Alvimopan—Constipation—Diphenhydramine—atopic dermatitis	0.0049	0.0255	CcSEcCtD
Alvimopan—Malnutrition—Fluocinolone Acetonide—atopic dermatitis	0.00486	0.0253	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.00479	0.0249	CcSEcCtD
Alvimopan—Constipation—Pimecrolimus—atopic dermatitis	0.00474	0.0247	CcSEcCtD
Alvimopan—Back pain—Fluocinolone Acetonide—atopic dermatitis	0.0047	0.0245	CcSEcCtD
Alvimopan—Back pain—Mometasone—atopic dermatitis	0.00449	0.0234	CcSEcCtD
Alvimopan—Urinary tract disorder—Tacrolimus—atopic dermatitis	0.00419	0.0218	CcSEcCtD
Alvimopan—Connective tissue disorder—Tacrolimus—atopic dermatitis	0.00417	0.0217	CcSEcCtD
Alvimopan—Urethral disorder—Tacrolimus—atopic dermatitis	0.00416	0.0217	CcSEcCtD
Alvimopan—OPRK1—GPCR ligand binding—CCL27—atopic dermatitis	0.0041	0.00515	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00408	0.00512	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.004	0.00502	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00399	0.00501	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—CCR5—atopic dermatitis	0.00398	0.005	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00398	0.00499	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00389	0.00489	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCL22—atopic dermatitis	0.00389	0.00488	CbGpPWpGaD
Alvimopan—Dyspepsia—Loratadine—atopic dermatitis	0.00389	0.0202	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.00381	0.0198	CcSEcCtD
Alvimopan—OPRD1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00381	0.00479	CbGpPWpGaD
Alvimopan—Constipation—Loratadine—atopic dermatitis	0.00378	0.0196	CcSEcCtD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.0037	0.00465	CbGpPWpGaD
Alvimopan—Malnutrition—Tacrolimus—atopic dermatitis	0.0037	0.0192	CcSEcCtD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00369	0.00464	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CCL17—atopic dermatitis	0.00368	0.00462	CbGpPWpGaD
Alvimopan—Flatulence—Tacrolimus—atopic dermatitis	0.00364	0.0189	CcSEcCtD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00362	0.00454	CbGpPWpGaD
Alvimopan—Back pain—Tacrolimus—atopic dermatitis	0.00358	0.0186	CcSEcCtD
Alvimopan—OPRM1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00356	0.00447	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00356	0.00447	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00349	0.00439	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00349	0.00438	CbGpPWpGaD
Alvimopan—Hypokalaemia—Hydrocortisone—atopic dermatitis	0.00348	0.0181	CcSEcCtD
Alvimopan—OPRM1—GPCR ligand binding—CCL27—atopic dermatitis	0.00347	0.00435	CbGpPWpGaD
Alvimopan—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00343	0.0178	CcSEcCtD
Alvimopan—Anaemia—Tacrolimus—atopic dermatitis	0.00342	0.0178	CcSEcCtD
Alvimopan—OPRD1—GPCR ligand binding—CCL11—atopic dermatitis	0.00338	0.00424	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—NFKBIA—atopic dermatitis	0.00338	0.00424	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00337	0.00423	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00334	0.0042	CbGpPWpGaD
Alvimopan—Dyspepsia—Mometasone—atopic dermatitis	0.00334	0.0174	CcSEcCtD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00329	0.00413	CbGpPWpGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00328	0.00412	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00324	0.00406	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00323	0.00405	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00323	0.00405	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00322	0.00404	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00317	0.00398	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00316	0.00397	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00313	0.00393	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCL17—atopic dermatitis	0.00311	0.0039	CbGpPWpGaD
Alvimopan—Hypokalaemia—Betamethasone—atopic dermatitis	0.00298	0.0155	CcSEcCtD
Alvimopan—Hypokalaemia—Dexamethasone—atopic dermatitis	0.00298	0.0155	CcSEcCtD
Alvimopan—OPRK1—GPCR ligand binding—CCL11—atopic dermatitis	0.00296	0.00372	CbGpPWpGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00296	0.00371	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00295	0.0037	CbGpPWpGaD
Alvimopan—OPRK1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00288	0.00361	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00283	0.00355	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00283	0.00355	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00282	0.00355	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00282	0.00354	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00277	0.00348	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00277	0.00348	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CCR3—atopic dermatitis	0.00276	0.00346	CbGpPWpGaD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00274	0.00344	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL22—atopic dermatitis	0.00269	0.00338	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00268	0.00337	CbGpPWpGaD
Alvimopan—Dyspepsia—Tacrolimus—atopic dermatitis	0.00266	0.0138	CcSEcCtD
Alvimopan—OPRD1—GPCR downstream signaling—CCL27—atopic dermatitis	0.00264	0.00332	CbGpPWpGaD
Alvimopan—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.0026	0.0135	CcSEcCtD
Alvimopan—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.0026	0.0135	CcSEcCtD
Alvimopan—Hypokalaemia—Prednisone—atopic dermatitis	0.00259	0.0135	CcSEcCtD
Alvimopan—OPRK1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00259	0.00325	CbGpPWpGaD
Alvimopan—Constipation—Tacrolimus—atopic dermatitis	0.00258	0.0134	CcSEcCtD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00256	0.00321	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCL11—atopic dermatitis	0.00251	0.00315	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—CD4—atopic dermatitis	0.0025	0.00314	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00249	0.00313	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—NPS—atopic dermatitis	0.00246	0.00308	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—TAC1—atopic dermatitis	0.00246	0.00308	CbGpPWpGaD
Alvimopan—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.00245	0.0127	CcSEcCtD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00243	0.00305	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00243	0.00305	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CCR3—atopic dermatitis	0.00242	0.00303	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CXCR3—atopic dermatitis	0.00241	0.00302	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL27—atopic dermatitis	0.0024	0.00301	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00239	0.003	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00239	0.003	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00238	0.00299	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL22—atopic dermatitis	0.00236	0.00296	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00234	0.00294	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CCL27—atopic dermatitis	0.00232	0.00291	CbGpPWpGaD
Alvimopan—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00231	0.00291	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—IL1B—atopic dermatitis	0.00231	0.0029	CbGpPWpGaD
Alvimopan—Malnutrition—Hydrocortisone—atopic dermatitis	0.00231	0.012	CcSEcCtD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00224	0.00281	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.0022	0.00276	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00219	0.00275	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00219	0.00275	CbGpPWpGaD
Alvimopan—Malnutrition—Methylprednisolone—atopic dermatitis	0.00217	0.0113	CcSEcCtD
Alvimopan—OPRK1—GPCR ligand binding—NPS—atopic dermatitis	0.00215	0.0027	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—TAC1—atopic dermatitis	0.00215	0.0027	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL17—atopic dermatitis	0.00215	0.0027	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	0.00212	0.00266	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CXCR3—atopic dermatitis	0.00211	0.00265	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL27—atopic dermatitis	0.0021	0.00264	CbGpPWpGaD
Alvimopan—Back pain—Triamcinolone—atopic dermatitis	0.0021	0.0109	CcSEcCtD
Alvimopan—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00205	0.00258	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	0.00204	0.00256	CbGpPWpGaD
Alvimopan—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00203	0.00255	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	0.002	0.0025	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00198	0.00249	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	0.00196	0.00246	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CXCL10—atopic dermatitis	0.00195	0.00244	CbGpPWpGaD
Alvimopan—Connective tissue disorder—Prednisone—atopic dermatitis	0.00194	0.0101	CcSEcCtD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00193	0.00242	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00189	0.00238	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL17—atopic dermatitis	0.00189	0.00237	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00185	0.00232	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	0.00182	0.00229	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	0.00182	0.00229	CbGpPWpGaD
Alvimopan—OPRD1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.00179	0.00224	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	0.00179	0.00224	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	0.00178	0.00223	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00174	0.00218	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL11—atopic dermatitis	0.00173	0.00218	CbGpPWpGaD
Alvimopan—Malnutrition—Prednisone—atopic dermatitis	0.00172	0.00893	CcSEcCtD
Alvimopan—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00172	0.00215	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FCER2—atopic dermatitis	0.00171	0.00215	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CXCL10—atopic dermatitis	0.00171	0.00214	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CCL5—atopic dermatitis	0.00168	0.0021	CbGpPWpGaD
Alvimopan—Dyspepsia—Hydrocortisone—atopic dermatitis	0.00166	0.00862	CcSEcCtD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00163	0.00205	CbGpPWpGaD
Alvimopan—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.00162	0.00845	CcSEcCtD
Alvimopan—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	0.0016	0.002	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL22—atopic dermatitis	0.00159	0.002	CbGpPWpGaD
Alvimopan—Anaemia—Prednisone—atopic dermatitis	0.00159	0.00825	CcSEcCtD
Alvimopan—OPRK1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.00157	0.00197	CbGpPWpGaD
Alvimopan—Dyspepsia—Triamcinolone—atopic dermatitis	0.00156	0.00811	CcSEcCtD
Alvimopan—OPRD1—GPCR downstream signaling—CCR3—atopic dermatitis	0.00156	0.00196	CbGpPWpGaD
Alvimopan—Dyspepsia—Methylprednisolone—atopic dermatitis	0.00156	0.0081	CcSEcCtD
Alvimopan—OPRK1—Signaling by GPCR—CCL11—atopic dermatitis	0.00152	0.00191	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CCR5—atopic dermatitis	0.00151	0.0019	CbGpPWpGaD
Alvimopan—OPRD1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.00151	0.00189	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FCER2—atopic dermatitis	0.0015	0.00188	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CCL5—atopic dermatitis	0.00147	0.00185	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00147	0.00184	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	0.00144	0.00181	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL27—atopic dermatitis	0.00142	0.00178	CbGpPWpGaD
Alvimopan—Dyspepsia—Dexamethasone—atopic dermatitis	0.00142	0.00736	CcSEcCtD
Alvimopan—Dyspepsia—Betamethasone—atopic dermatitis	0.00142	0.00736	CcSEcCtD
Alvimopan—OPRD1—Signaling by GPCR—CCR3—atopic dermatitis	0.00141	0.00178	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL22—atopic dermatitis	0.00139	0.00175	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—NPS—atopic dermatitis	0.00139	0.00174	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—TAC1—atopic dermatitis	0.00139	0.00174	CbGpPWpGaD
Alvimopan—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.00139	0.00722	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.00139	0.00722	CcSEcCtD
Alvimopan—OPRK1—GPCR downstream signaling—CCR3—atopic dermatitis	0.00137	0.00171	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00136	0.00171	CbGpPWpGaD
Alvimopan—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	0.00135	0.0017	CbGpPWpGaD
Alvimopan—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.00132	0.00166	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	0.00132	0.00166	CbGpPWpGaD
Alvimopan—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.00132	0.00166	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	0.00129	0.00162	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	0.00129	0.00161	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	0.00127	0.0016	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	0.00127	0.00159	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	0.00126	0.00158	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	0.00126	0.00158	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	0.00124	0.00156	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	0.00124	0.00156	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	0.00124	0.00156	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	0.00124	0.00155	CbGpPWpGaD
Alvimopan—Dyspepsia—Prednisone—atopic dermatitis	0.00123	0.00641	CcSEcCtD
Alvimopan—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	0.00122	0.00153	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	0.00122	0.00153	CbGpPWpGaD
Alvimopan—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.0012	0.00151	CbGpPWpGaD
Alvimopan—Constipation—Prednisone—atopic dermatitis	0.0012	0.00623	CcSEcCtD
Alvimopan—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00119	0.0015	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	0.00118	0.00148	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	0.00117	0.00147	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	0.00115	0.00145	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	0.00113	0.00142	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	0.00113	0.00142	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	0.00112	0.0014	CbGpPWpGaD
Alvimopan—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.00112	0.0014	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	0.00111	0.0014	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	0.00111	0.00139	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	0.00111	0.00139	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.0011	0.00138	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	0.00108	0.00136	CbGpPWpGaD
Alvimopan—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.00105	0.00132	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	0.00105	0.00132	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	0.00105	0.00132	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	0.00103	0.00129	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	0.00103	0.00129	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	0.00103	0.00129	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	0.00102	0.00129	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	0.00102	0.00129	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00101	0.00127	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000999	0.00125	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	0.000994	0.00125	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000965	0.00121	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	0.000964	0.00121	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	0.000956	0.0012	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000947	0.00119	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	0.000942	0.00118	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	0.000934	0.00117	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	0.000934	0.00117	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000916	0.00115	CbGpPWpGaD
Alvimopan—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000913	0.00115	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	0.000899	0.00113	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	0.000899	0.00113	CbGpPWpGaD
Alvimopan—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000888	0.00112	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000876	0.0011	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	0.000868	0.00109	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	0.00086	0.00108	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000853	0.00107	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	0.000845	0.00106	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	0.00084	0.00105	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	0.000835	0.00105	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000831	0.00104	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000815	0.00102	CbGpPWpGaD
Alvimopan—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000801	0.001	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	0.000775	0.000973	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	0.00076	0.000954	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	0.00076	0.000954	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	0.000754	0.000947	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000748	0.000939	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	0.000745	0.000935	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NPS—atopic dermatitis	0.000745	0.000935	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000741	0.00093	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	0.000733	0.00092	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	0.00073	0.000917	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	0.000714	0.000896	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000702	0.000881	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL5—atopic dermatitis	0.000692	0.000869	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	0.000679	0.000853	CbGpPWpGaD
Alvimopan—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000677	0.000849	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NPS—atopic dermatitis	0.000653	0.00082	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	0.000653	0.00082	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	0.00064	0.000804	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	0.000637	0.0008	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000632	0.000794	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	0.000619	0.000777	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL5—atopic dermatitis	0.000607	0.000762	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	0.00059	0.000741	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	0.000574	0.000721	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	0.000552	0.000693	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NPS—atopic dermatitis	0.000552	0.000693	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	0.000541	0.000679	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	0.000518	0.00065	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000516	0.000648	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL5—atopic dermatitis	0.000513	0.000644	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	0.000508	0.000638	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	0.000493	0.000619	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NGF—atopic dermatitis	0.000471	0.000591	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000468	0.000588	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	0.000458	0.000575	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000452	0.000568	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	0.000448	0.000562	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	0.000446	0.000559	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	0.000437	0.000549	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	0.000432	0.000543	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NGF—atopic dermatitis	0.000413	0.000518	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000411	0.000516	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	0.000401	0.000504	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	0.000393	0.000493	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000388	0.000487	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000382	0.00048	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	0.000377	0.000473	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	0.000365	0.000459	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NGF—atopic dermatitis	0.000349	0.000438	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000347	0.000436	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	0.00034	0.000427	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	0.000339	0.000426	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	0.000332	0.000417	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000288	0.000361	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	0.000277	0.000347	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL2—atopic dermatitis	0.000264	0.000332	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	0.000263	0.00033	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	0.000243	0.000306	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	0.000243	0.000305	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL2—atopic dermatitis	0.000232	0.000291	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	0.000231	0.00029	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	0.000213	0.000268	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	0.000205	0.000257	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL2—atopic dermatitis	0.000196	0.000246	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	0.000195	0.000245	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	0.00018	0.000227	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6—atopic dermatitis	0.000155	0.000195	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6—atopic dermatitis	0.000136	0.000171	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6—atopic dermatitis	0.000115	0.000145	CbGpPWpGaD
